https://investors.alnylam.com/press-release?id=22946
Alnylam Pharmaceuticals Press Release | Aug 10, 2018 | Alnylam Announces First-Ever FDA Approval of...
Alnylam Announces First-Ever FDA Approval of an RNAi Therapeutic, ONPATTRO™ (patisiran) for the Treatment of the Polyneuropathy of Hereditary...
pharmaceuticals press release
https://www.globenewswire.com/news/heathcare/pharmaceuticals
Pharmaceuticals Press Release News | GlobeNewswire
Browse the latest Pharmaceuticals press release news, including photos and multimedia, distributed by GlobeNewswire.
pharmaceuticals press release